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The human genome has been subjected to selective
pressures to resist to infectious agents in spite
of a heavy segregational load. With this regard,
thalassaemia and glucose-6-phosphate dehydroge-
nase deficiency have been considered an efficient
genetic protection against P. falciparum malaria in
Sardinia, insular Italy1,2.  In this island, some mul-
tiple sclerosis (MS)-associated HLA haplotypes
have the highest odds ratios in the same highest-
rate malarious areas of the island3. Moreover, tu-
mor necrosis factor (TNF) polymorphisms epide-
miologically associated with both MS and malaria
are ten-fold more frequent amongst Sardinians com-
pared to other populations worldwide4. A possible
association between MS and malaria in this island
was never analysed experimentally. We studied the
immunological response of mononuclear cells to
P. falciparum and the killing effect of macrophag-
es on parasites in Sardinian MS patients and in
matched healthy controls (HC).
Altogether 12 Sardinian MS patients (mean age 29 ±
5 years) and 12 matched healthy controls of same
ethnicity were enrolled in this study. All individuals
gave written consent to participate in the study.
Parasitised erythrocytes were lysed with 0.05%
saponin PBS and pellet sonicated six times on ice
with Bandelin Sonopuls. A mixture of P. falciparum
antigens was obtained; 2 x 105 mononuclear cell
(MNC)/well from MS and HC were plated in
duplicate on a microtiter plate alone or added with
either 10 µg/ml  lipopolysaccharide (LPS) or P.
falciparum lysate (1 Plasmodium/MNC). After 48
h, a stimulation index (SI) was calculated as the unit
of proliferation measurement ( SI = Mean count of
duplicate cultures with LPS/Mean counts of
duplicated cultures without LPS x 100) (Fig. 1).
Compared to the background level of proliferation
of the untreated MNC (assuming it as 100%) there
was a highly significant difference of the anti-P.
falciparum proliferative response, but not of the LPS-
driven response between the two groups: 158.3 ±
23% in MS and 121.7 ± 19.5% in HC, respectively
(p = 0.01; Fig. 1).
We also performed a P. falciparum inhibition test in
the presence of macrophages from MS and HC
(Fig.  2). The macrophage containing adherent frac-
tion of MNC was identified by flow cytometry and
dispensed in eight replicates on a microtiter plate add-
ed with P. falciparum cultures. Parasite growth was
determined by measuring its lactate dehydrogenase
activity (pLDH)5 with a spectrophotometer at 650 nm.
P. falciparum growth was inhibited by 8.8 ± 6.5% with
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macrophages from HC and by 36 ± 7.2% with mac-
rophages from MS patients (p = 0.001; Fig. 2).
In this study we report that P. falciparum, but not
LPS-driven proliferative MNC response was signif-
icantly elevated in MS compared to controls of same
ethnicity. These data indicate that Sardinian individ-
uals affected by MS have a stronger anti-P. falci-
parum response than healthy controls. To our knowl-
edge this is the first report of such an association,
suggesting the possibility that malaria may have se-
lected genetic traits  in Sardinia. Perhaps not coinci-
dentally and not justified by improved diagnosis6, a
3-fold increase of MS incidence subsequently oc-
curred beginning from 19507,8. In 1951, the WHO-
coordinated campaign eradicated malaria from Sar-
dinia. This increased incidence over time still remains
an unsolved enigma but, being a 50-year span too
short for a genetic change, an environmental change
is a likely reason for the increased risk. Our experi-
mental evidences indicate that some patterns of mac-
rophage response formerly positively selected against
severe forms of P. falciparum malaria, may now in-
crease the susceptibility toward abnormal immune-
mediated conditions, such as MS.
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Fig. 1: Stimulation index of non-stimulated (untreated, green
bar, assuming it as 100%), LPS-stimulated and P.
falciparum-stimulated peripheral blood mononuclear
cells (MNC) from 12 Sardinian MS patients (MS, red
bars) and 12 Sardinian healthy donors (HC, blue bars);
LPS and P. falciparum stimulated MNC proliferate
enormously as compared to their relative untreated
MNC (see text); P. falciparum-driven proliferation of
MS MNC is significantly higher as compared to HC
(p < 0.01)
Fig. 2: Proportion of pLDH activity of P. falciparum in three
different conditions: untreated (green bar, 100%
activity), treated with macrophages from HC (blue bar,
12 subjects) and from MS (red bar, 12 subjects). As
compared to the untreated condition there is a
significant reduction of P. falciparum growth when
using MS-derived macrophages as compared to HC-
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